Not medical advice. This site explains research. It is not a diagnosis, a dose, or a treatment plan.

Mito.newsMito.news
← All articlesEditorial brief · abstract-levelScore 95/100Confidence medium

The phospholipase of peroxiredoxin 6, not its peroxidase, keeps mitophagy and cristae intact in HepG2 cells

Not medical advice. This brief explains a preprint. It is not a diagnosis, a dose, or a treatment plan.

Peroxiredoxin 6 has a peroxidase activity and a separate calcium-independent phospholipase A2 activity. In HepG2 liver-cancer cells, a D140A mutation that stops only the phospholipase raised lipid peroxidation, ferrous iron, and ferroptosis sensitivity, lowered glutathione peroxidase 4, thinned cristae, and weakened mitophagy, while reactive oxygen species stayed low. The knockout, which removes both activities, was worse.

Mito.news · at a glance

Signal profile (abstract-level)

peroxiredoxin 6 · ferroptosis · mitophagy · ferrous iron

Score 95/100BIORXIVmedium confidenceperoxiredoxin 6
95
Importance
60
Mito signal
81
Dysfunction
83
Evidence
58
Translational

Editorial signal profile from the abstract (importance score, mito keywords, dysfunction tags, evidence density, translational cues). Not a figure reproduced from the preprint PDF.

Peroxiredoxin 6 is one protein with two chemical jobs. It is a peroxidase, and it is a calcium-independent phospholipase A2. This preprint separates those jobs in HepG2 cells, a human liver-cancer cell line.

The authors built a stable line carrying D140A, a mutation they use to turn off only the phospholipase. They compared it with wild-type cells and with cells that lack the protein entirely. D140A cells kept reactive oxygen species low, in line with wild-type cells. The authors read that as evidence that the oxidative stress of the full knockout comes from losing the peroxidase.

Lipid peroxidation did not follow the reactive oxygen species. D140A cells peroxidized more lipid than wild-type cells, and less than the knockout. On ferrous iron, lipid droplets, and glutathione peroxidase 4, the phospholipase mutant looked like the knockout: iron accumulated, lipid-droplet formation fell, and glutathione peroxidase 4 was down. Proteomics, lipidomics, and enzyme assays pointed to a failure to release lipid species the cells use for structure and signaling. Peroxisomes, endoplasmic reticulum, mitochondria, and lipid droplets were all affected.

In mitochondria the abstract is specific. Cristae were reduced. Mitophagy and autophagy were diminished. The cells died more readily when challenged with erastin, an experimental inducer of ferroptosis. The authors also report that the inhibitor MJ33 lowered phospholipase activity to a level comparable to D140A. That is a cell-line observation. It is not a therapy.

Metal and redox

The iron species named here is intracellular ferrous iron. Glutathione peroxidase 4 is named as a ferroptosis regulator that fell. The peroxidase activity of peroxiredoxin 6 is the control that stayed intact in D140A, which is why reactive oxygen species stayed low. No iron-sulfur nuclearity, no heme, and no copper site is reported. Do not add one.

What this does not show

The work is a preprint in one cancer cell line, read here from the abstract. The missing lipids are not named. Ferrous iron is not traced to a particular enzyme. This page is not a treatment plan, and it does not recommend MJ33 or any other inhibitor.

Free HTML is above. Bots pay for JSON at /api/v1/papers/10-64898-2026-11-06-764823. Optional wallet tester: MetaMask ($0.005).

Source preprint

The Phospholipase A2 Activity of Peroxiredoxin 6 Protects Hepatocarcinoma Cells Against Ferroptosis and Mitophagy Impairment

10.64898/2026.11.06.764823

Ortiz-Alcantara A, Ortiz-Olivencia A, Gonzalez-Ojeda R, McDonagh B, Requejo-Aguilar R, Padilla CA.

Related briefs